Showing results (881-890 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|January 21, 2020
Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine FibroidsAmanda Harrington, Nicole G Bonine, Erika Banks, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2020
Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United StatesVijay N Joish, Fang Liz Zhou, Ronald Preblick, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2020
Importance of Patient-Centered Outcomes When Evaluating Treatments for Secondary Progressive Multiple SclerosisTaddei-Allen PattyJournal of Managed Care & Specialty Pharmacy|April 1, 2020
Evaluating a Stone of Hope: ICER's 2019 Review of Treatments for Duchenne Muscular DystrophyJohn Frederick BrandsemaJournal of Managed Care & Specialty Pharmacy|April 1, 2020
The Authors RespondDaniel R Touchette, Foluso Agboola, Steven J Atlas, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral AntidepressantsSwapna Karkare, Hoa H Le, John J Sheehan, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar SurveillanceJie Zhang, Gayathri Sridhar, Charles E Barr, et al.Journal of Managed Care & Specialty Pharmacy|December 29, 2022
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertensionCharles D Burger, Benjamin Wu, Peter Classi, et al.Journal of Managed Care & Specialty Pharmacy|December 29, 2022
Inconsistencies in the days supply values reported in pharmacy claims databases for biologics with long maintenance intervalsChang Xu, Shannon A Ferrante, Timothy Fitzgerald, et al.Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS studyKristin A Evans, Michael Pollack, Edward Portillo, et al.Pageof 185